Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders
Fierce Pharma
Mon, 10/18/21 - 10:49 pm
Tags:
Regeneron, Novo Nordisk, Eli Lilly, AbbVie, television ads, DTC ads, diabetes, immunology
Regeneron Antibody Cocktail a Priority for FDA with April Action Date
BioSpace
Fri, 10/15/21 - 12:35 pm
Tags:
Regeneron, FDA, priority review, COVID-19, antibodies
Regeneron Could Have a Big Catalyst Coming in 2022
Motley Fool
Sat, 10/9/21 - 11:11 pm
Tags:
Regeneron, Libtayo, cervical cancer, FDA, Sanofi
J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race
Fierce Biotech
Mon, 10/4/21 - 11:08 am
Tags:
JNJ, Xencor, biobucks, Roche, Regeneron, bispecific antibodies, blood cancers, plamotamab
Regeneron's COVID-19 antibody cocktail reduces hospitalization risk by 71%, study shows
Beckers Hospital Review
Sun, 10/3/21 - 08:39 pm
Tags:
Regeneron, COVID-19, antibodies
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Fierce Pharma
Sun, 10/3/21 - 08:27 pm
Tags:
cancer, oncology, cancer immunotherapy, Merck, AstraZeneca, Regeneron, Sanofi
ESMO21: Libtayo extends survival in first-line NSCLC, challenging Keytruda
Pharmaforum
Mon, 09/20/21 - 11:07 am
Tags:
Sanofi, Regeneron, Libtayo, ESMO, non-small cell lung cancer, Merck, Keytruda
Surging US demand triggers new $2.9B purchase of Regeneron's Covid-19 antibodies
Endpoints
Wed, 09/15/21 - 10:47 am
Tags:
Regeneron, COVID-19, antibodies, government contract
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Fierce Biotech
Mon, 08/30/21 - 11:03 am
Tags:
Pfizer, abrocitinib, atopic dermatitis, Dupixent, Sanofi, Regeneron, clinical trials
It's back: Eli Lilly's COVID-19 antibody combo makes its return after 2 months on the sidelines
Fierce Pharma
Mon, 08/30/21 - 10:59 am
Tags:
Eli Lilly, antibodies, COVID-19, Regeneron, GSK, bamlanivimab-etesevimab
Brii gets a Covid-19 antibody boost
EP Vantage
Wed, 08/25/21 - 11:09 am
Tags:
Brii Biosciences, COVID-19, antibodies, Regeneron
Regeneron earns mid-stage win for higher dose of Eylea, hoping to refresh its sales pitch
Endpoints
Tue, 08/24/21 - 10:51 am
Tags:
Regeneron, Eylea, clinical trials, wet age-related macular degeneration
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Tags:
Gilead Sciences, Regeneron, AstraZeneca, FDA, PROs, oncology, clinical trials, patient-reported outcomes
Novartis says trials back Beovu safety in diabetic eye disease
Pharmaforum
Tue, 08/17/21 - 10:08 am
Tags:
Novartis, Beovu, diabetic macular edema, Bayer, Regeneron, Eylea
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Fierce Biotech
Mon, 08/16/21 - 12:25 pm
Tags:
Eli Lilly, lebrikizumab, Sanofi, Regeneron, Dupixent, atopic dermatitis, clinical trials
Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk
Fierce Pharma
Fri, 08/6/21 - 12:22 pm
Tags:
DTC advertising, television ads, Dupixent, Regeneron, Sanofi
Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field
BioPharma Dive
Thu, 08/5/21 - 11:02 pm
Tags:
Regeneron, Sanofi, Libtayo, clinical trials, lung cancer
With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised
Fierce Pharma
Mon, 08/2/21 - 10:56 am
Tags:
Regeneron, FDA, COVID-19, REGEN-COV
Lilly’s lebrikizumab looks to outdo Dupixent
EP Vantage
Mon, 08/2/21 - 10:48 am
Tags:
Eli Lilly, lebrikizumab, atopic dermatitis, Dupixent, Sanofi, Regeneron
New Drug Proves to Ease the Itch for Chronic Spontaneous Urticaria
BioSpace
Sat, 07/31/21 - 10:18 pm
Tags:
Regeneron, Sanofi, Dupixent, clinical trials, chronic spontaneous urticaria

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.